Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines

Pertaining to ST-segment-elevation myocardial infarction

W. Frank Peacock, Deepak L. Bhatt, Deborah Diercks, Ezra Amsterdam, Abhinav Chandra, E. Magnus Ohman, David F M Brown, James Januzzi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We sought to determine U.S. physicians' knowledge and perspectives regarding the 2004 American College of Cardiology/American Heart Association guidelines for management of patients who have ST-segment-elevation myocardial infarction (STEMI). We invited 45,998 physicians from the American Medical Association's roster to take an Internet survey of U.S. cardiologists and emergency physicians who were hospital-based or who had hospital-admitting privileges. To represent individual and combined populations, data were weighted on the basis of years in practice, sex, and geographic region. Of 505 cardiologists and 509 emergency physicians who completed the survey, 90% worked in an urban or suburban setting and 82% at hospitals with a cardiac catheterization laboratory. Sampling error was ±3.4%. Most respondents (61%) believed that overall myocardial infarction treatment needed a "great deal" or "fair amount" of improvement; 24% were "somewhat" or "not at all" familiar with the guidelines. Although 84% knew the recommended STEMI treatments for a patient who presents within 3 hours of symptom onset without contraindications to reperfusion or delay to invasive treatment, only 11% knew that there is no preferred approach. If percutaneous coronary intervention proved impossible within 90 minutes of presentation, 21% reported that eligible patients -assuming early presentation, confirmed STEMI diagnosis, and no high-risk STEMI or contraindications to fibrinolysis - would "rarely" or "never" receive guideline-recommended fibrinolysis. Many cardiologists and emergency physicians are unfamiliar with the guidelines and with the uncertainty that surrounds therapeutic approaches, which suggests the need for increased education on effective treatments to expedite myocardial reperfusion in STEMI.

Original languageEnglish (US)
Pages (from-to)152-161
Number of pages10
JournalTexas Heart Institute Journal
Volume35
Issue number2
StatePublished - 2008

Fingerprint

Reperfusion
Emergencies
Guidelines
Physicians
Fibrinolysis
Therapeutics
Myocardial Reperfusion
Selection Bias
American Medical Association
Percutaneous Coronary Intervention
Cardiac Catheterization
Internet
Uncertainty
Myocardial Infarction
ST Elevation Myocardial Infarction
Cardiologists
Education
Population
Surveys and Questionnaires

Keywords

  • Angioplasty, transluminal, percutaneous coronary/standards/utilization
  • Cardiovascular diseases/epidemiology/mortality
  • Chronology as topic
  • Delivery of health care/standards
  • Fibrinolysis
  • Guideline adherence
  • Hospitals/standards

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines : Pertaining to ST-segment-elevation myocardial infarction. / Peacock, W. Frank; Bhatt, Deepak L.; Diercks, Deborah; Amsterdam, Ezra; Chandra, Abhinav; Ohman, E. Magnus; Brown, David F M; Januzzi, James.

In: Texas Heart Institute Journal, Vol. 35, No. 2, 2008, p. 152-161.

Research output: Contribution to journalArticle

Peacock, W. Frank ; Bhatt, Deepak L. ; Diercks, Deborah ; Amsterdam, Ezra ; Chandra, Abhinav ; Ohman, E. Magnus ; Brown, David F M ; Januzzi, James. / Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines : Pertaining to ST-segment-elevation myocardial infarction. In: Texas Heart Institute Journal. 2008 ; Vol. 35, No. 2. pp. 152-161.
@article{6d89312737e146f1946351214e8d9123,
title = "Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines: Pertaining to ST-segment-elevation myocardial infarction",
abstract = "We sought to determine U.S. physicians' knowledge and perspectives regarding the 2004 American College of Cardiology/American Heart Association guidelines for management of patients who have ST-segment-elevation myocardial infarction (STEMI). We invited 45,998 physicians from the American Medical Association's roster to take an Internet survey of U.S. cardiologists and emergency physicians who were hospital-based or who had hospital-admitting privileges. To represent individual and combined populations, data were weighted on the basis of years in practice, sex, and geographic region. Of 505 cardiologists and 509 emergency physicians who completed the survey, 90{\%} worked in an urban or suburban setting and 82{\%} at hospitals with a cardiac catheterization laboratory. Sampling error was ±3.4{\%}. Most respondents (61{\%}) believed that overall myocardial infarction treatment needed a {"}great deal{"} or {"}fair amount{"} of improvement; 24{\%} were {"}somewhat{"} or {"}not at all{"} familiar with the guidelines. Although 84{\%} knew the recommended STEMI treatments for a patient who presents within 3 hours of symptom onset without contraindications to reperfusion or delay to invasive treatment, only 11{\%} knew that there is no preferred approach. If percutaneous coronary intervention proved impossible within 90 minutes of presentation, 21{\%} reported that eligible patients -assuming early presentation, confirmed STEMI diagnosis, and no high-risk STEMI or contraindications to fibrinolysis - would {"}rarely{"} or {"}never{"} receive guideline-recommended fibrinolysis. Many cardiologists and emergency physicians are unfamiliar with the guidelines and with the uncertainty that surrounds therapeutic approaches, which suggests the need for increased education on effective treatments to expedite myocardial reperfusion in STEMI.",
keywords = "Angioplasty, transluminal, percutaneous coronary/standards/utilization, Cardiovascular diseases/epidemiology/mortality, Chronology as topic, Delivery of health care/standards, Fibrinolysis, Guideline adherence, Hospitals/standards",
author = "Peacock, {W. Frank} and Bhatt, {Deepak L.} and Deborah Diercks and Ezra Amsterdam and Abhinav Chandra and Ohman, {E. Magnus} and Brown, {David F M} and James Januzzi",
year = "2008",
language = "English (US)",
volume = "35",
pages = "152--161",
journal = "Texas Heart Institute Journal",
issn = "0730-2347",
publisher = "Texas Heart Institute",
number = "2",

}

TY - JOUR

T1 - Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines

T2 - Pertaining to ST-segment-elevation myocardial infarction

AU - Peacock, W. Frank

AU - Bhatt, Deepak L.

AU - Diercks, Deborah

AU - Amsterdam, Ezra

AU - Chandra, Abhinav

AU - Ohman, E. Magnus

AU - Brown, David F M

AU - Januzzi, James

PY - 2008

Y1 - 2008

N2 - We sought to determine U.S. physicians' knowledge and perspectives regarding the 2004 American College of Cardiology/American Heart Association guidelines for management of patients who have ST-segment-elevation myocardial infarction (STEMI). We invited 45,998 physicians from the American Medical Association's roster to take an Internet survey of U.S. cardiologists and emergency physicians who were hospital-based or who had hospital-admitting privileges. To represent individual and combined populations, data were weighted on the basis of years in practice, sex, and geographic region. Of 505 cardiologists and 509 emergency physicians who completed the survey, 90% worked in an urban or suburban setting and 82% at hospitals with a cardiac catheterization laboratory. Sampling error was ±3.4%. Most respondents (61%) believed that overall myocardial infarction treatment needed a "great deal" or "fair amount" of improvement; 24% were "somewhat" or "not at all" familiar with the guidelines. Although 84% knew the recommended STEMI treatments for a patient who presents within 3 hours of symptom onset without contraindications to reperfusion or delay to invasive treatment, only 11% knew that there is no preferred approach. If percutaneous coronary intervention proved impossible within 90 minutes of presentation, 21% reported that eligible patients -assuming early presentation, confirmed STEMI diagnosis, and no high-risk STEMI or contraindications to fibrinolysis - would "rarely" or "never" receive guideline-recommended fibrinolysis. Many cardiologists and emergency physicians are unfamiliar with the guidelines and with the uncertainty that surrounds therapeutic approaches, which suggests the need for increased education on effective treatments to expedite myocardial reperfusion in STEMI.

AB - We sought to determine U.S. physicians' knowledge and perspectives regarding the 2004 American College of Cardiology/American Heart Association guidelines for management of patients who have ST-segment-elevation myocardial infarction (STEMI). We invited 45,998 physicians from the American Medical Association's roster to take an Internet survey of U.S. cardiologists and emergency physicians who were hospital-based or who had hospital-admitting privileges. To represent individual and combined populations, data were weighted on the basis of years in practice, sex, and geographic region. Of 505 cardiologists and 509 emergency physicians who completed the survey, 90% worked in an urban or suburban setting and 82% at hospitals with a cardiac catheterization laboratory. Sampling error was ±3.4%. Most respondents (61%) believed that overall myocardial infarction treatment needed a "great deal" or "fair amount" of improvement; 24% were "somewhat" or "not at all" familiar with the guidelines. Although 84% knew the recommended STEMI treatments for a patient who presents within 3 hours of symptom onset without contraindications to reperfusion or delay to invasive treatment, only 11% knew that there is no preferred approach. If percutaneous coronary intervention proved impossible within 90 minutes of presentation, 21% reported that eligible patients -assuming early presentation, confirmed STEMI diagnosis, and no high-risk STEMI or contraindications to fibrinolysis - would "rarely" or "never" receive guideline-recommended fibrinolysis. Many cardiologists and emergency physicians are unfamiliar with the guidelines and with the uncertainty that surrounds therapeutic approaches, which suggests the need for increased education on effective treatments to expedite myocardial reperfusion in STEMI.

KW - Angioplasty, transluminal, percutaneous coronary/standards/utilization

KW - Cardiovascular diseases/epidemiology/mortality

KW - Chronology as topic

KW - Delivery of health care/standards

KW - Fibrinolysis

KW - Guideline adherence

KW - Hospitals/standards

UR - http://www.scopus.com/inward/record.url?scp=47249083468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249083468&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 152

EP - 161

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

SN - 0730-2347

IS - 2

ER -